S. J. Leaw, C. J. Yen, W. T. Huang, T. Y. Chen and W. C. Su, C. J. Tsao, “Preemptive Use of Interferon or Lamivudine for Hepatitis B Reactivation in Patients with Aggressive Lymphoma Receiving Chemotherapy,” Annals of Hematology, Vol. 83, No. 5, 2004, pp. 270-275.

has been cited by the following article:

• TITLE: Occult Hepatitis B Flare-up after Chemotherapy Treatment in HBsAg Negative Patient

  AUTHORS: Shoaib Ahmad, Vu Le, Tauseef Ali

  KEYWORDS: Hepatitis B, Chemotherapy, Reactivation

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.2 No.5, November 28, 2011

  ABSTRACT: Reactivation of Hepatitis B virus causing liver damage is a concern in patients with chronic HBV infections who receive immunosuppressive or cytotoxic treatments. HBV screening should be considered for all patients going to receive immunosuppressive regimens which have the potential to induce reactivation of HBV infection. We discuss here a case of occult Hepatitis B flare after chemotherapy in a patient who had negative acute hepatitis profile including HBsAg prior to therapy and baseline serum AST, ALT, INR, albumin, bilirubin and serum creatinine were within normal limits.